Table 2 Clinical stage at diagnosis prevalence according to diagnosis and treatment characteristics of uveal melanoma in Brazil
Variables | Initial disease (I or II) | Metastases (regional or distant) | Missing/do not apply | Total | p value |
|---|---|---|---|---|---|
Nc (%a) | Nc (%a) | Nc (%a) | Nc (%b) | ||
Year of diagnosisd | 0.680 | ||||
2000 a 2012 | 356 (20.1) | 273 (15.4) | 1138 (64.4) | 1767 (81.6) | |
2013 a 2016 | 73 (18.3) | 61 (15.3) | 265 (66.4) | 399 (18.4) | |
Time from diagnosis to treatment | 0.005 | ||||
≤ 60 days | 236 (24.7) | 183 (19.2) | 535 (56.1) | 954 (59.4) | |
> 60 days | 150 (23.0) | 89 (13.7) | 412 (63.3) | 651 (40.6) | |
No treatment | 27 | 34 | 304 | 365 | |
Missing | 16 | 28 | 152 | 196 | |
Response to the first course of treatmente | < 0.001 | ||||
Response | 43 (11.9) | 28 (7.8) | 290 (80.3) | 361 (76.8) | |
No response | 4 (3.7) | 29 (26.6) | 76 (69.7) | 109 (23.2) | |
No treatment | 27 | 34 | 304 | 365 | |
Missing | 355 | 243 | 733 | 1331 | |
Total | 429 (19.8) | 334 (15.4) | 1403 (64.8) | 2166 (100.0) |